ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
醫藥外包概念
2,829.161
-5.212
-0.18%
手動刷新
漲家數:
3
跌家數:
4
平家數:
1
市盈率:
- -
高:
2,850.996
開:
2,832.450
低:
2,762.928
收:
2,834.373
成交量:
1.07億
成交額:
34.68億
市值:
6,402.08億
流通市值:
2,744.66億
資料載入中...
總覽
新聞
易方達基金減持泰格醫藥(03347)417.44萬股 每股作價約44.34港元
智通财经
·
昨天
一次治療長期獲益?“天價抗癌藥”仍需破解商業化難題
猛犸资本局
·
昨天
每日賣空追蹤 | 泰格醫藥 09月16日賣空量成交7.17萬股,賣空比例為3.19%
市场透视
·
昨天
每日賣空追蹤 | 藥明康德 09月16日賣空量成交36.51萬股,賣空比例為5.58%
市场透视
·
昨天
每日賣空追蹤 | 藥明生物 09月16日賣空量成交438.9萬股,賣空比例為12.94%
市场透视
·
昨天
藥明生物09月16日主力淨流出1643.1萬元 散户資金買入
市场透视
·
昨天
醫藥ETF嘉實開盤漲0.00%,重倉股藥明康德跌0.47%,恆瑞醫藥漲0.00%
动脉网
·
昨天
智通港股早知道 | 預製菜食品安全標準即將發佈 國家外匯管理局允許外商直接投資項下外匯利潤境內再投資
智通财经
·
昨天
康龍化成(03759.HK):康龍紹興順利通過美國FDA現場質量檢查
智通财经
·
09/15
康龍化成公告全資附屬公司康龍化成(紹興)藥業有限公司於2025年5月29日至2025年6月4日接受了美國食品藥品監督管理
智通财经
·
09/15
康龍化成(300759.SZ)子公司康龍紹興通過美國FDA現場檢查
智通财经
·
09/15
康龍化成公告全資子公司康龍化成(紹興)藥業有限公司於2025年5月29日至2025年6月4日接受了美國FDA的cGMP上
智通财经
·
09/15
下一個黃金十年,藥明生物仍是最好的選擇
药时代
·
09/15
昭衍新藥(06127.HK):A股股票交易異常波動 不存在應披露而未披露的重大信息
智通财经
·
09/15
2024年醫藥CRO行業發展現狀、競爭格局及未來發展趨勢分析
中研网
·
09/15
支持三類新藥,創新藥臨牀試驗審評審批增設30日通道
大洋网
·
09/15
昭衍新藥連續3個交易日收盤價格漲幅偏離值累計超20%
财中社
·
09/15
JPMorgan Chase & Co持有藥明康德H股長倉比例從6.71%降至6.01% - 港交所9月10日數據
美股速递
·
09/15
【國投證券 | 醫藥】CXO研究框架:從需求、供給、政策多維度全面揭示CXO景氣度和發展週期
国投证券医药研究
·
09/15
每日賣空追蹤 | 康龍化成 09月15日賣空量成交52.41萬股,賣空比例為2.08%
市场透视
·
09/15
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":2829.1606,"timestamp":1758010150348,"preClose":2834.3726,"halted":0,"volume":106555515,"delay":0,"changeRate":-0.001839,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-5.211914,"latestTime":"09-16 16:00:00","open":2832.4502,"high":2850.9958,"low":2762.9277,"amount":3467983710,"amplitude":0.031071,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1758072600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1757986200000,1757995200000],[1757998800000,1758009600000]],"pbRate":3.434702,"peRate":15.063103,"turnoverRate":0.009143,"increases":3,"decrements":3,"flats":2,"marketCap":640208461312,"floatMarketCap":274465786624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":2850.9958,"amplitude":0.031071,"preClose":2834.3726,"low":2762.9277,"pbRate":"3.434702","latestPrice":2829.1606,"volume":106555515,"delay":0,"open":2832.4502,"prevYearClose":1395.7731,"prevWeekClose":2725.899,"prevMonthClose":2563.018,"prevQuarterClose":1988.255,"fiveDayClose":2798.2,"twentyDayClose":2413.834,"sixtyDayClose":1914.155,"secType":"PLATE","market":"HK","turnoverRate":0.009143,"peRate":15.063103,"marketCap":640208461312,"floatMarketCap":274465786624,"timestamp":1758010150348,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":3,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567101907","title":"易方達基金減持泰格醫藥(03347)417.44萬股 每股作價約44.34港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567101907","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567101907?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 19:07","pubTimestamp":1758020854,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月11日,易方达基金减持泰格医药(03347)417.44万股,每股作价44.3362港元,总金额约为1.85亿港元。减持后最新持股数目为1237.03万股,持股比例为10.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345901.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1576","LU1146622755.USD","BK0077","BK0174","BK0028","BK1141","LU1820825898.SGD","300347","03347","BK1583"],"gpt_icon":0},{"id":"2568482148","title":"一次治療長期獲益?“天價抗癌藥”仍需破解商業化難題","url":"https://stock-news.laohu8.com/highlight/detail?id=2568482148","media":"猛犸资本局","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568482148?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 18:20","pubTimestamp":1758018022,"startTime":"0","endTime":"0","summary":"《蓝皮书》认为,细胞基因治疗可能是“终极”治疗手段,有望实现“一次治疗,长期获益”。同时,针对治疗传统“不可成药”的疾病,如多种单基因遗传病、某些神经退行性疾病因其靶点特殊,使用传统小分子或抗体药物难以有效干预,但细胞和基因疗法直接绕过“成药性”难题。根据ASGCT数据,截至2025年第一季度末,全球细胞与基因治疗领域研发管线,共有4418项疗法处于研发阶段,比2023年底增长11.8%。商业化难题如何破局?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916195429979604a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916195429979604a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU0052750758.USD","LU2242644610.SGD","BK1583","LU2045819591.USD","LU0320764599.SGD","BK1576","02359","LU2125910500.SGD","BK1141","LU0708995583.HKD"],"gpt_icon":0},{"id":"2567103511","title":"每日賣空追蹤 | 泰格醫藥 09月16日賣空量成交7.17萬股,賣空比例為3.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567103511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567103511?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:30","pubTimestamp":1758011434,"startTime":"0","endTime":"0","summary":"泰格医药北京时间09月16日,涨0.16%,卖空量成交7.17万股,较上一交易日增加1.27%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091616345195311563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091616345195311563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","03347","BK1583"],"gpt_icon":0},{"id":"2568048211","title":"每日賣空追蹤 | 藥明康德 09月16日賣空量成交36.51萬股,賣空比例為5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568048211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568048211?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:30","pubTimestamp":1758011430,"startTime":"0","endTime":"0","summary":"药明康德北京时间09月16日,跌1.52%,卖空量成交36.51万股,较上一交易日减少22.55%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161634069795a214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161634069795a214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2045819591.USD","LU2242644610.SGD","LU0708995583.HKD","LU2125910500.SGD","BK1141","BK1576","LU0320764599.SGD","BK1583","02359","LU1046422090.SGD"],"gpt_icon":0},{"id":"2567517078","title":"每日賣空追蹤 | 藥明生物 09月16日賣空量成交438.9萬股,賣空比例為12.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567517078","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567517078?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:30","pubTimestamp":1758011430,"startTime":"0","endTime":"0","summary":"药明生物北京时间09月16日,跌0.21%,卖空量成交438.9万股,较上一交易日减少31.21%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161633559795a207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509161633559795a207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0979878070.USD","LU0348735423.USD","LU0140636845.USD","LU0708995583.HKD","LU0516422440.USD","LU2039709279.SGD","LU0326950275.SGD","SG9999002463.SGD","LU0417516902.SGD","LU0516423091.SGD","LU0572944931.SGD","LU1720050803.USD","LU0320764599.SGD","LU0588546209.SGD","LU0516423174.USD","BK1610","LU0348825331.USD","LU0307460666.USD","LU0417516738.SGD","LU0516422952.EUR","LU0043850808.USD","BK1589","LU0823426308.USD","BK1576","BK1521","LU0039217434.USD","LU0359201612.USD","BK1141","LU1242518931.SGD","LU0052750758.USD","LU0359202008.SGD","LU0456846285.SGD","LU0327786744.USD","LU0456827905.SGD","LU0819121731.USD","LU1794554557.SGD","LU0181495838.USD","SG9999002562.SGD","LU1242518857.USD","LU1688375341.USD","LU0856984785.SGD","IE00B0JY6N72.USD","LU0051755006.USD","LU0516422366.SGD","02269","LU1880383366.USD","LU0823426480.USD"],"gpt_icon":0},{"id":"2567081031","title":"藥明生物09月16日主力淨流出1643.1萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567081031","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567081031?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 16:16","pubTimestamp":1758010564,"startTime":"0","endTime":"0","summary":"09月16日, 药明生物股价跌0.21%,报收38.76元,成交金额13.0亿元,换手率0.83%,振幅3.04%,量比0.59。药明生物今日主力资金净流出1643.1万元,上一交易日主力净流入8744.5万元。该股近5个交易日上涨3.51%,主力资金累计净流出855.5万元;近20日主力资金累计净流入8.5亿元,其中净流入天数为16日。该股主力净额占比0.01%,港股市场排名2315/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091616233095310f1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091616233095310f1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1880383366.USD","LU0516423174.USD","BK1521","LU0823426480.USD","LU0456827905.SGD","LU0417516738.SGD","SG9999002562.SGD","LU0051755006.USD","LU0516422952.EUR","LU0359202008.SGD","LU0417516902.SGD","LU0181495838.USD","LU1242518857.USD","LU0819121731.USD","LU1720050803.USD","LU0516422440.USD","LU0039217434.USD","LU1242518931.SGD","LU1794554557.SGD","LU0456846285.SGD","LU0043850808.USD","LU0823426308.USD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0856984785.SGD","LU0307460666.USD","SG9999002463.SGD","LU0140636845.USD","BK1589","LU0348735423.USD","BK1610","LU0327786744.USD","LU0320764599.SGD","02269","BK1141","BK1576","LU0516422366.SGD","LU0052750758.USD","LU2039709279.SGD","LU0708995583.HKD","LU0516423091.SGD","LU0588546209.SGD","LU1688375341.USD","LU0359201612.USD","LU0326950275.SGD","LU0979878070.USD","LU0348825331.USD"],"gpt_icon":0},{"id":"2567105564","title":"醫藥ETF嘉實開盤漲0.00%,重倉股藥明康德跌0.47%,恆瑞醫藥漲0.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567105564","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567105564?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 09:36","pubTimestamp":1757986560,"startTime":"0","endTime":"0","summary":"9月16日,医药ETF嘉实(515960)开盘价与前一交易日持平,报0.921元。其重仓股中,药明康德开盘跌0.47%,恒瑞医药、科伦药业开盘价与前一交易日持平,迈瑞医疗涨0.04%,华东医药、新和成均涨0.12%,长春高新跌0.40%,复星医药涨1.00%,信立泰涨0.11%,爱美客涨0.01%。该ETF业绩比较基准为中证医药健康100策略指数收益率,由嘉实基金管理有限公司管理,基金经理为王紫菡。自2020年4月24日成立以来,该基金回报率为-7.79%,但近一个月回报率为3.97%。市场有风险,投资需谨慎,本文信息仅供参考,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091609473095304af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091609473095304af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU2125910500.SGD","01276","02359","LU2045819591.USD","LU2242644610.SGD","BK1141","BK1191","LU0052750758.USD","LU0708995583.HKD","LU0359201612.USD","BK1583","LU2543165471.USD","LU0359202008.SGD","LU1046422090.SGD","BK1576","LU0320764599.SGD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2567312567","title":"智通港股早知道 | 預製菜食品安全標準即將發佈 國家外匯管理局允許外商直接投資項下外匯利潤境內再投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2567312567","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567312567?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 07:26","pubTimestamp":1757978817,"startTime":"0","endTime":"0","summary":"预制菜食品安全标准即将发布据财联社报道,国家卫健委主导的《预制菜食品安全国家标准》草案已通过专家审查,即将向社会公开征求意见。国家外汇管理局:允许外商直接投资项下外汇利润境内再投资智通财经APP获悉,9月15日,国家外汇管理局发布《关于深化跨境投融资外汇管理改革有关事宜的通知》,其中提到,允许外商直接投资项下外汇利润境内再投资。书面通知发出后,《实施协议》和《股份认购协议》立即终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1604","03759","LU2488822045.USD","BK1237","HSCEI","06862","HSTECH","BK4614","YANG","BK1576","09985","BK1589","BK1141","BK1233","BK1583","BK1591"],"gpt_icon":1},{"id":"2567116467","title":"康龍化成(03759.HK):康龍紹興順利通過美國FDA現場質量檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116467","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116467?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 19:30","pubTimestamp":1757935845,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03759","BK0216","300759","BK1141","PAI.AU","BK1576","PAI"],"gpt_icon":0},{"id":"2567811669","title":"康龍化成公告全資附屬公司康龍化成(紹興)藥業有限公司於2025年5月29日至2025年6月4日接受了美國食品藥品監督管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2567811669","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567811669?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 19:23","pubTimestamp":1757935381,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0216","03759","BK1576","BK1141","300759"],"gpt_icon":0},{"id":"2567511396","title":"康龍化成(300759.SZ)子公司康龍紹興通過美國FDA現場檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=2567511396","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567511396?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:37","pubTimestamp":1757932653,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康龙化成(300759.SZ)公告,公司全资子公司康龙化成(绍兴)药业有限公司(简称“康龙绍兴”)于2025年5月29日至2025年6月4日接受了来自美国食品药品监督管理局(简称“美国FDA”)的cGMP(现行药品生产质量管理规范)上市批准前检查(PAI),检查范围涵盖质量体系、物料管理体系、生产管理体系、设备设施体系、包装和标签体系、实验室控制体系等各GMP系统。近日,康龙绍兴收到美国FDA出具的现场检查报告。该检查报告确认,康龙绍兴的生产设施顺利通过美国FDA的现场质量检查。根据该检查报告,康龙绍兴符合美国药品cGMP质量标准,通过了美国FDA认证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03759","BK0216","BK1141","300759"],"gpt_icon":0},{"id":"2567118007","title":"康龍化成公告全資子公司康龍化成(紹興)藥業有限公司於2025年5月29日至2025年6月4日接受了美國FDA的cGMP上","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567118007?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:25","pubTimestamp":1757931944,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0216","BK1576","300759","03759","BK1141"],"gpt_icon":0},{"id":"2567116717","title":"下一個黃金十年,藥明生物仍是最好的選擇","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116717","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116717?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 18:22","pubTimestamp":1757931741,"startTime":"0","endTime":"0","summary":"2025年,恰逢药审改革十周年,中国创新药已成为全球生物制药板块中举足轻重的一部分。今年上半年,药明生物综合项目数再次迎来高增长。下一个黄金十年,药明生物仍是最好的选择在中国创新药量质齐升,声名远扬的当下,其高性价比也正密集吸引海外药企慕名来中国“买药”。选择药明生物,获得创新药从研发到商业化生产“端到端”的赋能,正是“出海”最好的选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915190358952ecdc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915190358952ecdc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","LU0348735423.USD","LU1720050803.USD","BK1610","LU0516423174.USD","02269","IE00B0JY6N72.USD","LU0051755006.USD","LU0327786744.USD","BK1576","LU0823426308.USD","LU0181495838.USD","LU0823426480.USD","LU0417516902.SGD","BK1589","LU0516422366.SGD","LU0979878070.USD","SG9999002562.SGD","LU1242518931.SGD","BK1141","LU0307460666.USD","LU0819121731.USD","LU0417516738.SGD","LU0516422952.EUR","LU0516422440.USD","LU0456846285.SGD","LU0326950275.SGD","LU0359201612.USD","LU0320764599.SGD","LU0140636845.USD","LU1242518857.USD","LU0039217434.USD","LU1688375341.USD","LU0572944931.SGD","LU0348825331.USD","LU0043850808.USD","BK1521","LU0708995583.HKD","LU1794554557.SGD","LU0052750758.USD","LU0359202008.SGD","LU0456827905.SGD","LU1880383366.USD","LU2039709279.SGD","SG9999002463.SGD","LU0516423091.SGD","LU0856984785.SGD"],"gpt_icon":1},{"id":"2567906101","title":"昭衍新藥(06127.HK):A股股票交易異常波動 不存在應披露而未披露的重大信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2567906101","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567906101?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:36","pubTimestamp":1757929014,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["399300","603127","BK1576","159982","BK0216","BK1141","06127"],"gpt_icon":0},{"id":"2567111925","title":"2024年醫藥CRO行業發展現狀、競爭格局及未來發展趨勢分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2567111925","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567111925?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:36","pubTimestamp":1757929011,"startTime":"0","endTime":"0","summary":"医药CRO是医药研发外包服务的核心载体,其业务覆盖药物发现、临床前研究、临床试验及注册申报等全链条环节。近年来,AI技术在药物发现、临床试验设计及数据分析等环节的应用显著提升了研发效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915173659a4c72cb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915173659a4c72cb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","03759","BK1161","03347","BK1576","06127","BK1141","BK1574","09939"],"gpt_icon":0},{"id":"2567175581","title":"支持三類新藥,創新藥臨牀試驗審評審批增設30日通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2567175581","media":"大洋网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567175581?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:28","pubTimestamp":1757928480,"startTime":"0","endTime":"0","summary":"国家药监局日前发布并实施《关于优化创新药临床试验审评审批有关事项的公告》,对符合要求的创新药临床试验申请,在药物临床试验60日默示许可基础上增设创新药临床试验审评审批30日通道。国家药监局在公告解读文件中披露的最新数据显示,我国药品临床试验审评审批平均用时已缩减至约50个工作日,有力推动了创新药研发提速,支持了我国药物研发产业链融入全球研发体系,加快新药好药上市步伐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915175908a722014b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915175908a722014b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06978","BK1161","BK1141","03347","BK1576","BK1574"],"gpt_icon":0},{"id":"2567784197","title":"昭衍新藥連續3個交易日收盤價格漲幅偏離值累計超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567784197","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567784197?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:23","pubTimestamp":1757928210,"startTime":"0","endTime":"0","summary":"昭衍新药(603127/06127)发布公告,公司股票在2025年9月11日、9月12日和9月15日连续3个交易日,收盘价格涨幅偏离值累计超过20%。2025年中期,昭衍新药实现收入6.69亿元,归母净利润6093万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509153513836896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"1182792957","title":"JPMorgan Chase & Co持有藥明康德H股長倉比例從6.71%降至6.01% - 港交所9月10日數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1182792957","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182792957?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 17:13","pubTimestamp":1757927596,"startTime":"0","endTime":"0","summary":"根据港交所9月10日公布的数据,JPMorgan Chase & Co持有药明康德H股的长仓比例从此前的6.71%下降至6.01%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","LU0456842615.SGD","BK0216","LU2495084118.USD","LU1969619763.USD","LU0052750758.USD","603259","LU0320764599.SGD","02359","BK1583","LU2045819591.USD","LU1997245177.USD","LU1808992512.USD","LU2125910500.SGD","LU1934453819.USD","LU1997244956.HKD","LU2488822045.USD","LU0708995583.HKD","LU2328871848.SGD","LU1046422090.SGD","LU2242644610.SGD","LU1979443071.USD","LU1997245094.SGD","BK1141"],"gpt_icon":0},{"id":"2567116534","title":"【國投證券 | 醫藥】CXO研究框架:從需求、供給、政策多維度全面揭示CXO景氣度和發展週期","url":"https://stock-news.laohu8.com/highlight/detail?id=2567116534","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567116534?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 16:41","pubTimestamp":1757925685,"startTime":"0","endTime":"0","summary":"高定价的优质订单有利于提振CXO公司的盈利能力,同质化或低定价的订单则可能对公司盈利水平造成负面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091518300097934cf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091518300097934cf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","02269","LU1880383366.USD","LU0359201612.USD","LU0819121731.USD","LU0456827905.SGD","BK1515","BK1141","LU0359202008.SGD","LU1720050803.USD","LU0456846285.SGD","LU0856984785.SGD","03759","BK1574","LU0516422366.SGD","LU1242518931.SGD","LU0417516902.SGD","BK1521","LU0320764599.SGD","SG9999002463.SGD","LU1794554557.SGD","LU0327786744.USD","LU0588546209.SGD","SG9999002562.SGD","09939","LU0572944931.SGD","LU1242518857.USD","LU0708995583.HKD","LU0516423091.SGD","LU0823426480.USD","BK1589","06821","LU0348735423.USD","LU0979878070.USD","LU0051755006.USD","BK1161","BK1610","LU0140636845.USD","LU0516422952.EUR","LU2039709279.SGD","LU0039217434.USD","LU0417516738.SGD","LU0823426308.USD","LU0181495838.USD","LU0348825331.USD","BK1576","LU1688375341.USD","LU0326950275.SGD","LU0516423174.USD","LU0052750758.USD","IE00B0JY6N72.USD","LU0043850808.USD"],"gpt_icon":1},{"id":"2567279701","title":"每日賣空追蹤 | 康龍化成 09月15日賣空量成交52.41萬股,賣空比例為2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567279701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567279701?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 16:30","pubTimestamp":1757925033,"startTime":"0","endTime":"0","summary":"康龙化成北京时间09月15日,涨9.38%,卖空量成交52.41万股,较上一交易日减少48.93%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915163421a721db47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250915163421a721db47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","BK1576","BK1141"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":178,"code":"91000000","status":"200"}]}}